Tamsulosin

Rediff.com » News » Tamsulosin

News for Tamsulosin

Business

Sun-Ranbaxy $4 billion merger completed

Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries on Tuesday said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals. In a......

Sun gets RBI nod for transfer of Ranbaxy overseas investments

Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of their......

Sun-Ranbaxy merger clears last hurdle

The merger gets Punjab & Haryana High Court go-ahead; deal to close after brand dilutions The $4-billion merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories has crossed the final......

Sun Pharma gets US trade regulator nod for Ranbaxy deal

The US Federal Trade Commission (FTC) has completed its review of the proposed $4 billion acquisition of Ranbaxy Laboratories by Sun Pharma and granted early termination of the waiting period under......

Sun gets US trade regulator nod for Ranbaxy merger

Gujarat-based Torrent also in the fray for India assets Drug major Sun Pharma is now a step closer to becoming the world’s fifth-largest generic drug company, as the US Federal Trade......

Rediff News

Tamsulosin

News for Tamsulosin

Sun-Ranbaxy $4 billion merger completed

Sun gets RBI nod for transfer of Ranbaxy overseas investments

Sun-Ranbaxy merger clears last hurdle

Sun Pharma gets US trade regulator nod for Ranbaxy deal

Sun gets US trade regulator nod for Ranbaxy merger

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS